Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC

Clinical trial NCT07540832 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07540832
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.